Formulation: A crystalline solid

Purity: ≥98%

• 2,5-dimethoxy-4-Iodoamphetamine

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• Ethylone
• MDEC
• bk-Methylenedioxyethylamphetamine
• ​3,4-Methylenedioxyethylcathinone
• 3,4-Methylenedioxy-N-ethylcathinone

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• 2C-I-NBOMe

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• bk-MMBDB
• Dibutylone
• Methylbutylone

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 2C-C-NBOMe

Formulation: A crystalline solid

Purity: ≥95%

• 2C-I-NBOH

Formulation: A crystalline solid

Purity: ≥95%

Schedule: I

• 4-Bromo-2,5-dimethoxyphenethylamine

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• 2C-B-NBOMe

Formulation: A crystalline solid

Purity: ≥98%

• 2C-C-NBOH

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• NSC 30419
• TMPEA

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Ritalinic Acid ethyl ester

Formulation: A neat solid

Purity: ≥98%

Formulation: A neat solid

Purity: ≥98%

• 3-fluoro Phenmetrazine
• 3-FMP
• 3-FPM
• 3-fluoro PM

Formulation: A neat solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

• 2C-D-NBOMe

Formulation: A crystalline solid

Purity: ≥98%

• 2-Amino-1-(8-bromobenzo[1,2-b;5,4-b']difuran-4-yl)propane
• 1-(8-Bromobenzo[1,2-b; 4,5-b']difuran-4-yl)-2-aminopropane
• DOB-DFLY

Schedule: I

• PEA

Schedule: I

Formulation: A neat solid

Purity: ≥98%

• Dimethylphenidate
• Ritalinic Acid isopropyl ester

Formulation: A crystalline solid

Purity: ≥98%

• bk-4-Bromo-2,5-dimethoxyphenethylamine

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Schedule: IV

• BTS-54524

Formulation: A neat solid

Purity: ≥98%

• EPE
• N-Ethyl-1,2-diphenylethylamine
• NEDPA
• NSC 33648